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ABSTRACT
Background: Chronic rhinosinusitis (CRS), which is clinically classified into CRS without nasal polyps
(CRSsNP) and CRS with nasal polyps (CRSwNP), shows considerable geographic differences and heteroge-
neity. Eosinophilic (E) CRS with nasal polyps (ECRSwNP) has a higher degree of disease severity and higher
frequency of comorbid asthma. Epidemiologic studies in different ethnic populations have improved under-
standing of the pathophysiology of the disease. Here we report the clinical characteristics of Japanese patients
with medically refractory CRS undergoing endoscopic sinus surgery (ESS).
Methods: We recruited a total of 210 CRS patients and assessed them by nasal endoscopy, the Lund-Mackay
score using computed tomography (CT), peripheral eosinophilia and smoking status. We also examined the
comorbidity of asthma, effects of age and lung functions in the patients.
Results: In this study, 13% of CRSwNP patients and 20% of CRSwNP patients with peripheral blood eosino-
philia exhibited obstructive lung dysfunction (FEV1FVC <70%) despite the absence of an asthma diagnosis.
Among elderly nonsmoker patients (60 years) who had never been diagnosed with asthma, 50% of CRSwNP
patients with peripheral blood eosinophilia showed decreased FEV1FVC <70%.
Conclusions: Our findings suggest that asthma is under-diagnosed in CRS patients who undergo ESS, espe-
cially the elderly. Although the association between CRS and asthma has been recognized, increased attention
to the comorbidity of obstructive airway diseases such as asthma is still needed for management of medically
refractory CRS.
KEY WORDS
asthma, chronic rhinosinusitis, eosinophils, lung functions, nasal polyps
INTRODUCTION
Chronic rhinosinusitis (CRS), a common disease as-
sociated with persistent inflammation of the nasal and
paranasal sinuses, is a public health problem result-
ing in a socioeconomic burden throughout the
world.1,2 CRS is commonly classified into two groups,
CRSsNP and CRSwNP. Considerable heterogeneity
within CRSwNP has been recognized and there are
geographic differences in the condition.3,4 Tissue
from Caucasian patients with CRSwNP is character-
ized by eosinophilic inflammation, whereas samples
from Asian patients are biased toward neutrophilic in-
flammation.3,4 Eosinophilic (E) CRSwNP has been
found in 65-90% of subjects with CRSwNP in Cauca-
sians and in 50% of them in East Asian populations.1-3
ECRSwNP represents a higher degree of disease se-
verity, with an impaired sense of smell, higher recur-
rence rate after surgery and higher frequency of
comorbid asthma.2 The association of ECRSwNP and
asthma is well recognized in western countries; 5,6
however, asthma comorbidity in CRSwNP patients in
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Table　1　Clinical characteristics of patients with chronic rhinosinusitis
CRSsNP
n = 40
CRSwNP
n = 170 P-value
Age (median, range) 57 (35-64) 54.5 (44-63) NS
Sex (male/female) (female %) 31/9 (23) 109/61 (36) NS
Smoker, no. (%) 21 (53) 56 (33) <0.05
Current smoker, no. (%) 21 (53) 46 (27) <0.01
Brinkman index of smokers 430 (290-728) 560 (300-854) NS
Asthma, no. (%) 2 (5) 44 (26) <0.01
Aspirin-induced asthma, no. (%) 0 (0) 10 (6) NS
Allergic rhinitis, no. (%) 8 (20) 48 (28) NS
Rhinorrhea, no. (%) 34 (85) 124 (73) NS
Nasal congestion, no. (%) 23 (58) 138 (81) <0.01
Headache, no. (%) 17 (43) 38 (22) <0.05
Olfactory dysfunction, no. (%) 11 (28) 112 (66) <0.0001
P values were determined using the Mann-Whitney U test, or Fisher’s exact test as appropriate. CRSwNP, chronic rhinosinusitis with 
nasal polyps; CRSsNP, chronic rhinosinusitis without nasal polyps; NS, not signifi cant.
Asian countries has not been fully studied. Nor are
the clinical features of CRS such as sinus scores
evaluated by CT scanning and lung functions in Asian
populations well investigated.
Epidemiologic studies have shown that asthma and
rhinitis often coexist in the same patients and suggest
the ‘united airways’ concept.4,7-11 Underdiagnosis and
undertreatment of asthma is a significant public prob-
lem all over the world, especially in the elderly.12 The
awareness of asthma is frequent in those with comor-
bid rhinitis,13 and it has also been suggested that
symptoms may predominate in one organ and be un-
recognized in other organs even though they exist.8
A higher CT score and more nasal polyp formation
are observed in elderly patients with CRS.14 However,
the influence of aging on the clinical features of CRS
in Japanese patients has not been examined.
ESS is the treatment choice for medically refrac-
tory CRS with or without nasal polyposis.15 To clarify
the clinical features of refractory CRS in Japanese pa-
tients, we conducted a cross-sectional study with a to-
tal of 210 CRS patients who underwent ESS. We as-
sessed their clinical phenotypes through the use of
nasal endoscopy, considering peripheral eosinophilia,
CT scores based on the Lund-Mackay system, smok-
ing status, comorbidity of asthma, effects of age and
lung functions.
METHODS
SUBJECTS
CRS was defined as a condition with at least two of
the following symptoms: anterior andor posterior
rhinorrhea, nasal obstruction, decreased sense of
smell, and nasal pressure existing for 12 weeks de-
spite medical management.1,2 We recruited all pa-
tients with CRS who underwent ESS at the University
of Yamanashi Hospital from January 2002 to October
2011. All individuals were Japanese, and we excluded
patients with autoimmune disease, cancer, papilloma,
fungal infection, postoperative maxillary cysts, cho-
anal polyps, and nasal foreign bodies before enroll-
ment. We excluded patients with allergic fungal rhi-
nosinusitis based on CT andor histopathological
findings from the start. We included patients with uni-
lateral CRS and those with nasal polyps. The pres-
ence or absence of nasal polyps was confirmed by en-
doscopy. Finally, a total of 210 subjects were analyzed
(Table 1). CRS patients were classified into CRSwNP
and CRSsNP groups based on the criteria of the
American Academy of Otolaryngology-Head and
Neck Surgery Chronic Rhinosinusitis Task Force.1
Comorbidity of asthma was determined from the pa-
tients’ medical histories based on doctors’ interviews.
We defined individuals who had asthma diagnosed by
a doctor at any point in their lifetime as having bron-
chial asthma. This study was approved by the ethics
committee of the University of Yamanashi Hospital.
We informed patients that any clinical data would be
used for research analyses by placing a notice on
walls in the medical examination room and hospital
lobby in the University of Yamanashi Hospital. We in-
dividually responded to patients who dissented from
such use. In this study, we recruited subjects who did
not dissent from use of the clinical data. This process
of obtaining informed consent was approved by the eth-
ics committee of the University of Yamanashi Hospital.
PERIPHERAL EOSINOPHIL COUNT
A total of 19 patients (9%) were treated with systemic
corticosteroids in the two months before the opera-
tion, and 91 patients (43%) were treated with intrana-
sal steroids in the month before the operation. Since
the eosinophil count is sensitive to steroid treatment,
we recorded the highest peripheral blood eosinophil
percentage among all the blood tests done before op-
eration.
Features of Chronic Rhinosinusitis
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LUNG FUNCTION AND COMPUTED TOMOGRA-
PHY
Spirometry was performed for all patients using a
DISCOM 21 FXII spirometer (CHEST MI., Inc., To-
kyo, Japan). Forced expired volume in one second
(FEV1)forced vital capacity (FVC) (FEV1%) was cal-
culated. Maximum expiratory flow rates at 50% and
25% of the FVC (V50 and V25) were obtained from
flowvolume curves. FEF25-75 and lung functions af-
ter application of a bronchodilator were not available
for this study. CT scans of the sinuses were available
for 54 patients with CRSwNP and were graded based
on the Lund-Mackay staging system.16 We used the
average of the right and left side scores in the follow-
ing analyses.
HISTOLOGICAL ANALYSIS
It is well known that infiltration of eosinophils in nasal
polyps is a characteristic of ECRSwNP. However, it
remains unclear whether eosinophilic infiltration ex-
ists in nasal mucosal tissue of CRS without nasal
polyp involvement. To assess eosinophil infiltration in
sinonasal mucosal tissues without polyps, we exam-
ined the maxillary mucosa histologically. Among the
210 CRS patients enrolled in this study, non-polyp
mucosal tissues from the maxillary sinuses were ob-
tained from 46 CRSwNP patients. Paraffin-embedded
sections were stained with hematoxylin and eosin,
and the number of infiltrating eosinophils were
counted in four randomly selected high power (×400)
magnification fields.
STATISTICAL ANALYSIS
Demographic data, lung functions, and CT scores
were compared using the Mann-Whitney U test or
Fisher’s exact test. The correlational validity of the
peripheral blood eosinophil percentage with the mu-
cosal eosinophil count was assessed using Spearman
rank correlations. Statistical significance was set at P
< 0.05. All statistical analyses were performed using R
(R Development Core Team, http:www.r-project.or
g).
RESULTS
SUBJECTS’ CHARACTERISTICS
Of the 210 CRS patients who underwent ESS, 40
(19%) had CRSsNP and 170 (81%) had CRSwNP.
Clinical features of each group are shown in Table 1.
Current smokers were more frequent in the CRSsNP
group (53%) than in the CRSwNP group (27%). The
comorbidity of asthma was significantly higher for
CRSwNP (26%) than for CRSsNP (5%). Among sub-
jective symptoms, olfactory dysfunction was more fre-
quent in CRSwNP (66%) than in CRSsNP (28%).
Recent studies have shown that the blood eosino-
phil percentage is the most accurate clinical factor to
distinguish the eosinophilic type of CRSwNP from
the non-eosinophilic type;17,18 however, precise clini-
cal diagnostic criteria including the peripheral eosino-
phil percentage for ECRSwNP have not been deter-
mined. In this study, we divided the patients with
CRSwNP into two groups to clarify the clinical char-
acteristics of each group. Since the median value of
the eosinophil percentage of the total leukocyte count
in subjects with CRSwNP was 5%, we defined subjects
with an eosinophil percentage <5% as having
CRSwNP without peripheral blood eosinophilia and
subjects with5% as having CRSwNP with peripheral
blood eosinophilia. A total of 87 subjects (51%) were
classified into the CRSwNP group without peripheral
blood eosinophilia, and 83 subjects (49%) were classi-
fied into the group having CRSwNP with peripheral
blood eosinophilia (Table 2). The comorbidity of
asthma was significantly higher for CRSwNP with pe-
ripheral blood eosinophilia (43%) than for CRSwNP
without peripheral blood eosinophilia (9%), and the
comorbidity of aspirin-induced asthma (AIA) or aller-
gic rhinitis was significantly higher for CRSwNP with
peripheral blood eosinophilia than for the CRSwNP
without peripheral blood eosinophilia (Table 2). Ol-
factory dysfunction was also frequently observed in
the group having CRSwNP with peripheral blood
eosinophilia (Table 2).
CT SCORES IN PATIENTS WITH CRSwNP
The Lund-Mackay score is commonly used for as-
sessment of the stage and severity of CRS.16 We ex-
amined the severity of the disease in subjects with
CRSwNP using CT scores based on the Lund-Mackay
system. The total score for CRSwNP with peripheral
blood eosinophilia had a tendency to be higher than
that for CRSwNP without peripheral blood eosino-
philia (Fig. 1) but the difference was not statistically
significant (P = 0.051). There was no significant differ-
ence between CRSwNP without peripheral blood
eosinophilia and CRSwNP with peripheral blood
eosinophilia for the maxillary sinus score, sphenoid
sinus score, frontal sinus score, and ostiomeatal com-
plex score (data not shown). However, the anterior
ethmoid (AE) sinus score and posterior ethmoid
(PE) sinus score of CRSwNP with peripheral blood
eosinophilia were significantly higher those for
CRSwNP without peripheral blood eosinophilia (P <
0.05 and < 0.001, respectively) (Fig. 1).
CORRELATION BETWEEN EOSINOPHIL INFIL-
TRATION IN SINONASAL MUCOSA AND PE-
RIPHERAL BLOOD EOSINOPHIL COUNT IN PA-
TIENTS WITH CRSwNP
Infiltration of eosinophils in nasal polyps is a charac-
teristic of ECRSwNP. Since whether eosinophilic infil-
tration exists in nasal mucosal tissue of CRS without
nasal polyp involvement remains unknown, we inves-
tigated the correlation between blood and mucosal
eosinophilia in a total of 46 patients with CRSwNP.
The count of mucosal eosinophils strongly correlated
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Table　2　Clinical characteristics of patients with CRSwNP
CRSwNP (n = 170)
P-valuewithout peripheral 
blood eosinophilia 
n = 87
with peripheral 
blood eosinophilia 
n = 83
Age (median, range) 58 (45-66) 52 (44-61) NS
Sex (male/female) (female %) 54/33 (38) 55/28 (34) NS
Smoker, no. (%) 31 (36) 25 (31) NS
Current smoker, no. (%) 25 (29) 21 (26) NS
Brinkman Index of smokers (median, range) 730 (330-900) 460 (293-620) NS
Asthma, no. (%) 8 (9) 36 (43) <0.000001
Aspirin-intolerant asthma, no. (%) 1 (1) 9 (11) <0.01
Allergic rhinitis, no. (%) 16 (18) 32 (39) <0.01
Rhinorrhea, no. (%) 64 (74) 60 (72) NS
Nasal congestion, no. (%) 70 (81) 68 (82) NS
Headache, no. (%) 23 (26) 15 (18) NS
Olfactory dysfunction, no. (%) 49 (56) 63 (76) <0.01
P values were determined using the Mann-Whitney U test or Fisher’s exact test as appropriate. NS, not signifi cant.
with the peripheral blood eosinophil percentage (R =
0.67, P < 0.000001) (Fig. 2).
LUNG FUNCTIONS OF THE CRS PATIENTS
The close relationship between asthma and CRS is
widely recognized. We therefore assessed lung func-
tions of the CRS patients. We first excluded nine pa-
tients whose smoking histories were unknown from
the analysis. FEV1FVC was significantly lower in
subjects with CRSwNP than in subjects with
CRSsNP, and was also lower in the group having
CRSwNP with peripheral blood eosinophilia than in
the group having CRSwNP without peripheral blood
eosinophilia (Fig. 3a, Table 3). There were 18 pa-
tients being treated with corticosteroids among the
subjects whose lung functions were assessed. One
patient with CRSsNP (2.6%), two patients with
CRSwNP without peripheral blood eosinophilia (2.4%)
and 15 patients who had CRSwNP with peripheral
blood eosinophilia (19%) had received systemic corti-
costeroid treatment prior to surgery. Although there
were more patients receiving corticosteroids in the
group having CRSwNP with peripheral blood eosino-
philia than in the groups having CRSsNP and
CRSwNP without peripheral blood eosinophilia,
FEV1FVC was significantly lower in the subjects
who had CRSwNP with peripheral blood eosinophilia
than in the subjects of the other two CRS groups.
Furthermore, %V25 was lower in the CRSwNP group
than in the CRSsNP group, and both %V25 and %V50
were lower for CRSwNP with peripheral blood
eosinophilia than for CRSwNP without peripheral
blood eosinophilia (Table 3).
Decreased FEV1FVC is a clinical feature of ob-
structive lung diseases such as bronchial asthma and
chronic obstructive pulmonary disease (COPD).
Since smoking is the leading cause of COPD, we next
examined the influence of smoking status on lung
functions of subjects with CRSsNP and CRSwNP.
There was no significant difference in lung functions
(FEV1FVC, %V25, and %V50) between current smok-
ers, former smokers (smokers) and never smokers
(nonsmokers) among the entire group with CRS
(Fig. 3b, Table 3). After excluding current and former
smokers, FEV1FVC was lower in the CRSwNP
group than in the CRSsNP group, and was lower in
the CRSwNP group with peripheral blood eosino-
philia than in the CRSwNP group without peripheral
blood eosinophilia (Fig. 3c). Both %V25 and %V50
were lower in patients who had CRSwNP with periph-
eral blood eosinophilia than in those who had
CRSwNP without peripheral blood eosinophilia (Ta-
ble 3).
We next stratified the CRS patients who had never
been diagnosed with asthma prior to ESS by the
comorbidity of asthma, and focused on their lung
functions. Since obstruction has been traditionally de-
fined by an FEV1FVC ratio of less than a certain per-
centage, usually 70 to 75%,19 we divided subjects into
three classes according to their lung function: FEV1
FVC <70%, 70%FEV1FVC <75% and FEV1FVC
75% (Fig. 4). In 13% of patients with CRSwNP who
had never been diagnosed as having asthma, FEV1
FVC was less than 70% (Fig. 4a). Furthermore, 20% of
patients having CRSwNP with peripheral blood
eosinophilia had FEV1FVC of less than 70% despite
the absence of a previous asthma diagnosis (Fig. 4a).
The same tendency was observed even after exclud-
ing current and former smokers, and smoking status
did not influence the obstructive lung dysfunction in
subjects who had CRSwNP and CRSwNP with periph-
eral blood eosinophilia (Fig. 4b).
Features of Chronic Rhinosinusitis
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Fig.　1　Comparison of CT scores for CRSwNP with and without peripheral blood eosino-
philia. CT scores based on the Lund-Mackay staging system were compared between sub-
jects who had CRSwNP without peripheral blood eosinophilia (n = 28) and CRSwNP with 
peripheral blood eosinophilia P (n = 26). P values were determined using the Mann-Whitney 
U test. AE score, anterior ethmoid sinus score; PE score, posterior ethmoid sinus score.
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Fig.　2　Correlation between percentage of eosinophils in 
peripheral blood and the tissue eosinophil count in the mu-
cosa of the maxillary sinus. The tissue eosinophils of pa-
tients with CRSwNP (n = 46) were counted at high power 
maginifi cation (×400). Correlation validity was assessed by 
using Spearman rank correlations.
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Underdiagnosis of asthma is an important problem,
especially in the elderly.12 Therefore we further ex-
amined whether there were age-related differences in
the prevalence of each subgroup or in FEV1FVC.
We divided nonsmoker patients who had never been
diagnosed with asthma into nonelderly (<60 years)
and elderly groups (60 years). In the elderly group,
obstructive lung dysfunction (FEV1FVC <70%) was
more frequently seen in those with CRSwNP (28%)
than in those with CRSsNP (0%), and for CRSwNP
with peripheral blood eosinophilia (50%) than for
CRSwNP without peripheral blood eosinophilia (18%)
(Fig. 4c).
DISCUSSION
There is considerable heterogeneity within the
CRSwNP subgroup,3,4 and importance of understand-
ing CRS within the context of racial and ethnic popu-
lations has been suggested.20 This study revealed the
clinical characteristics of Japanese patients with medi-
cally refractory CRS who underwent ESS. Epidemi-
ologic studies have reported that rhinitis and asthma
often coexist in the same patients.1,5,6,8 The ‘united
airways’ concept implies that there is a link between
upper and lower airway inflammation.8,9,21 A recent
study reported the asthma comorbidity in patients
with CRSwNP who underwent ESS (n = 19) to be 32%
in Japanese patients.22 In the United States, the fre-
quencies of comorbidity of asthma were reported to
be 11% in those with CRSsNP and 44% in those with
CRSwNP.23 In this study, the frequency was 26% for
CRSwNP, and it was significantly higher for CRSwNP
with peripheral blood eosinophilia (43%) than for
CRSwNP without peripheral blood eosinophilia (9%).
The frequency of comorbidity of asthma observed in
the group having CRSwNP with peripheral blood
eosinophilia (43%) in our study was similar to that in
the CRSwNP group (44%) in the United States. Fur-
thermore, it has been reported that ECRSwNP has a
higher degree of disease severity in western coun-
tries.1 AIA represents a severe phenotype of asthma
and we found significantly higher comorbidity of AIA
for CRSwNP with peripheral blood eosinophilia than
for the CRSwNP without peripheral blood eosino-
philia in this study.
A recent report has shown that CRS patients with
anosmia have a higher density of eosinophils infiltrat-
ing the olfactory epithelium, and exhibit more abnor-
malities on CT and endoscopic examination, includ-
ing being more likely to exhibit nasal polyposis than
other CRS patients.24 We observed olfactory dysfunc-
tion with high frequency in subjects with CRSwNP
(66%), especially in those who had CRSwNP with pe-
ripheral blood eosinophilia (76%). Our findings sup-
port previous research results. CT scanning is useful
Tanaka S et al.
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Fig.　3　Comparison of FEV1/FVC ratios among subgroups of CRS. a) Comparison between 
CRSsNP and CRSwNP, and between CRSwNP with and without peripheral blood eosinophilia. 
b) Comparison between nonsmokers and (current and former) smokers among the entire group 
with CRS. c) Comparison between CRSsNP and CRSwNP, and between CRSwNP with and 
without peripheral blood eosinophilia after excluding current and former smokers. Rectangles in-
clude the range from the 25th to 75th percentiles, horizontal lines indicate the median and verti-
cal lines indicate the 10th to 90th percentiles. P values were determined using the Mann-Whitney 
U test. FVC, forced vital capacity; FEV1, forced expired volume in one second.
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Table　3　Lung functions of subgroups of CRS
CRS
P-value
Nonsmokers with CRS
P-value
CRSsNP (n = 39) CRSwNP (n = 162) CRSsNP (n = 19) CRSwNP (n = 112)
%FVC 105.0 (93.5-111.8) 106.7 (95.2-118.3) NS 102.0 (88.2-110.9) 107.8 (95.3-118.5) <0.05
%FEV1 102.5 (95.7-109.7) 101.5 (89.6-110.8) NS 106.5 (94.0-111.2) 103.3 (88.5-112.1) NS
FEV1/FVC 82.3 (77.4-85.6) 78.4 (72.5-82.6) <0.01 83.9 (80.2-86.3) 78.1 (72.4-81.4) <0.001
%V50 68.5 (61.4-85.7) 67.3 (45.7-83.9) NS 68.4 (60.7-76.1) 64 (43.8-81.9) NS
%V25 58.8 (44.2-66.2) 42.7 (29.3-55.3) <0.001 60.8 (52.7-66.2) 42.7 (27.7-54.5) <0.001
CRSwNP
P-value
Nonsmokers with CRSwNP
P-valuewithout peripheral 
blood eosinophilia 
P (n = 83)
with peripheral 
blood eosinophilia 
(n = 79)
without peripheral 
blood eosinophilia 
(n = 55)
with peripheral 
blood eosinophilia 
(n = 57)
%FVC 106.4 (94.7-113.2) 108.2 (97.5-121.0) NS 106.7 (95.1-113.2) 110.3 (97.6-121.6) NS
%FEV1 101.8 (91.9-112.9) 101.5 (80.1-108.5) NS 105.1 (92.6-114.4) 98.2 (78.1-108.8) NS
FEV1/FVC 79.5 (74.7-83.3) 75.3 (67.8-81.2) <0.01 79.4 (75.1-83.2) 74.4 (66.7-80.1) <0.01
%V50 69.6 (55.2-85.7) 58.5 (37.7-81.7) <0.01 68.3 (57.3-84.7) 53.5 (36.8-74.0) <0.01
%V25 45.6 (36.8-59.5) 40.9 (25.8-51.4) <0.01 45.1 (37.5-56.3) 38.7 (22.4-48.4) <0.01
Lung functions are expressed as percentages of predicted values and are presented as medians (interquartile ranges). P values were 
determined using the Mann-Whitney U test. FVC, forced vital capacity; FEV1, forced expired volume in one second; V50 and V25 of FVC,
maximum expiratory fl ow rates at 50% and 25%; FEV1%, FEV1/FVC %.
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Fig.　4　Obstructive lung dysfunctions of CRS patients who had never been diag-
nosed with asthma prior to ESS. a-c) Comparison between CRSsNP and CRSwNP, 
and between CRSwNP with and without peripheral blood eosinophilia. a) In total 
subjects. b) In subjects excluding current and former smokers. c) In elderly non-
smoker subjects (>60 years) who had never been diagnosed with asthma.
a  Total subjects who were never diagnosed with asthma
b  Nonsmokers who were never diagnosed with asthma
c  Elderly nonsmokers (>60 years) who were never diagnosed with asthma
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for the visualization of disease and enables us to de-
termine the extent of rhinosinusitis accurately. The
Lund-Mackay score evaluated on CT scans is widely
used in assessment of CRS.16 A recent study has
shown that an increased blood eosinophil percentage
and the CT image scores for the PE sinus and the ol-
factory cleft are good predictors of ECRSwNP.18 In
this study, although the total score for CRSwNP with
peripheral blood eosinophilia did not significantly dif-
fer from that for CRSwNP without peripheral blood
eosinophilia, the AE sinus and PE sinus scores of
CRSwNP with peripheral blood eosinophilia were sig-
nificantly higher than those for CRSwNP without pe-
ripheral blood eosinophilia. Thus, our results support
previous findings on involvement of the posterior eth-
moid sinus in ECRSwNP.
Infiltration and activation of eosinophils in nasal
polyps is a characteristic of eosinophilic CRSwNP,
and it has been reported that the peripheral blood
eosinophil percentage is positively correlated with
the number of eosinophils in nasal polyps.25 In this
study, we found eosinophilic infiltration in nasal mu-
cosal tissue not involving nasal polyps and a positive
correlation between blood and mucosal eosinophilia
in patients with CRSwNP. Thus, it is necessary to be
aware of the possibility of eosinophilic inflammation
not only in nasal polyps but also in nasal mucosa for
the treatment of CRSwNP patients with high blood
Tanaka S et al.
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eosinophil levels.
A recent report showed a high prevalence of as-
ymptomatic lower airway dysfunctions in patients
with CRSwNP in the United Kingdom.26 In this study,
28% of CRSwNP patients exhibited FEV1FVC of less
than 75%, and 20% of patients who had CRSwNP with
peripheral blood eosinophilia had FEV1FVC of less
than 70% despite the absence of an asthma diagnosis.
Decreased FEV1FVC (<70%) was more frequently
observed in patients having CRSwNP with peripheral
blood eosinophilia (21%) than in those having
CRSwNP without peripheral blood eosinophilia (9%),
even after excluding current and former smokers.
Never smokers comprise a substantial proportion of
patients with COPD; however, asymptomatic de-
creased lung function suggestive of an asthmatic phe-
notype was frequently observed in CRSwNP, espe-
cially in CRSwNP with peripheral blood eosinophilia.
Most patients with asthma have symptoms of rhinitis,
but in many cases symptoms may predominate in one
organ and be unrecognized in other organs even
though they exist.8 Our findings also suggest the ne-
cessity of paying increased attention to the possible
comorbidity of obstructive airway diseases such as
asthma for management of refractory CRS.
The underdiagnosis and undertreatment of asthma
are serious problems throughout the world,13,27-30 es-
pecially in the elderly.29 About half of elderly people
with asthma have not been diagnosed, and the un-
deruse of objective testing such as spirometry has
been considered to be one reason.30 In this study, af-
ter excluding patients who had ever been diagnosed
with asthma and current or former smokers, de-
creased FEV1FVC (<70%) tended to be more preva-
lent in elderly patients in the CRSwNP and CRSwNP
groups with peripheral blood eosinophilia. Although
FEV1FVC normally decreases with age and FEV1
FVC lower than 70% might be a normal finding, an
FEV1FVC ratio of less than 70% increases the prob-
ability of asthma in elderly patients with asthma
symptoms.30 Careful assessment of asthma by means
of systemic inquiries about respiratory symptoms and
objective testing by spirometry seems to be neces-
sary in subjects with refractory CRS, especially eld-
erly patients. Early diagnosis and good asthma con-
trol are important to reduce morbidity and healthcare
costs as well as minimize the development of chronic
illnesses,13 and appropriate diagnosis and manage-
ment of asthma would contribute to mitigating the se-
verity of their CRS.
In conclusion, we found that 19% of subjects with
CRS who underwent ESS had CRSsNP, and 81%
CRSwNP. We confirmed that both the AE and PE si-
nus CT scores of the Lund-Mackay staging system
were helpful for identifying CRSwNP with peripheral
blood eosinophilia. Obstructive lung dysfunctions are
frequently observed in CRSwNP with peripheral
blood eosinophilia, especially in elderly persons, de-
spite the absence of an asthma diagnosis. Although
further studies are needed, our findings will contrib-
ute to better understanding of the pathophysiology of
CRS.
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